Flagship presented three posters at the show, including: #AACR2021 poster no. 433: Clinical Validation of a Dickkopf-1 (DKK1) Chromogenic In-situ Hybridization (CISH) Assay for Manual and Image Analysis Assisted Pathologist Interpretation, in partnership with Leap...
Events
UPCOMING EVENTS
- American Society of Gene & Cell Therapy (ASGCT) Annual Meeting | May 7-11, Baltimore, MD (Booth #726)
- American Society of Clinical Oncology (ASCO) Annual Meeting | May 31 – June 4, Chicago, IL (Booth #37085)
- 3rd Annual Spatial Biology East Coast Congress | June 10-11, Boston, MA (Gold Sponsor)
- World CDx | September 4-6, Boston, MA (Spotlight Partner)
- Spatial Biology in Drug Development | October, Boston, MA (Program Partner)
SITC 2020
SITC 2020 November 9-14, 2020As we prepare our poster presentation for the (virtual) Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting, we encourage you to register now (members register for FREE!)
Webinar: Digital Pathology with Integrated PD-L1 AI, hosted by Flagship and Gestalt Diagnostics
Join Flagship Biosciences and our partners Gestalt Diagnostics for this informative webinar featuring an overview and discussion of the value of a truly integrated, digital pathology platform, using Artificial Intelligence (AI) to aid in diagnostic decisions! Flagship...
Regulatory Webcast RECORDING: Biomarker Strategies and Implementation in Drug Development
(Recorded live on Tuesday, July 14, 2020) Biomarkers are important tools for successful biopharmaceutical-targeted drug development and regulatory approval. Biomarkers can be diagnostic and/or prognostic, indicative of precision drug targeting. As such, biomarkers are...
Webcast RECORDING: Improving Clinical Trial Outcomes with Tissue Image Analysis: Case Studies
(Recorded live on Thursday, April 16, 2020) Image analysis of histological tissue sections is a fast-growing field that is becoming widely accepted as a research tool for scientists and pathologists, providing quantitative, reproducible data in lieu of varying manual...
AACR Virtual Meeting II – June 22-24, 2020
Flagship was a virtual exhibitor this year during the AACR Virtual Meeting II. Our scientists, led by Chuck Caldwell, shared a new poster during the virtual event.
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
NEWS
Flagship Spotlight: Roberto Gianani, MD
Introduction and BackgroundDr. Roberto Gianani, Chief Medical Officer at Flagship Biosciences, Inc., is a practicing pathologist who is board certified in anatomic pathology, clinical pathology, and pediatric pathology. He is fellowship-trained in surgical pathology...
Flagship Spotlight: Adam Beharry
Introduction and BackgroundAdam Beharry, PhD, is a Flagship scientist who describes his work as applying advanced technical knowledge and critical thinking to expand Flagship’s tissue image analysis in neuromuscular and rare diseases. Adam’s degrees include: BS –...
White Paper: Tissue Image Analysis and Biomarker Assessment Implementation Benefits and ROI
IntroductionThe success of clinical trials is highly dependent on the intricacies of patient recruitment. Other challenges, from the costs of clinical supplies to the specific procedural requirements that can extend physicians’ time, can increase costs. There are also...
PUBLICATIONS/POSTERS
Comprehensive Image Analysis Of Immunostained NSCLC Tissues Provides Necessary Context For Immune Oncology Biomarker Profiling
Key Takeaways Manual pathology assessment is challenging and variable, limiting the data interpretation required for meaningful spatial biology analysis Unlike manual assessment, artificial intelligence and machine learning technologies analyze the complex...
Artificial Intelligence Assisted Macrophage Identification in Tumor Biopsies
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning algorithm provided accurate macrophage classification This algorithm is useful in...
Analysis of Companion Diagnostic Potentials For Multifaceted PD-L1 Assays
ABSTRACT In vitro diagnostic (IVD) approvals of qualitative immunohistochemical (IHC) assays offer unique patient selection strategies by equipping pathologists with new tools to assess tumor status including tumor immune landscape. PD-L1/PD-1 checkpoint therapies...